MIST insider transactions
Milestone Pharmaceuticals Inc. (MIST) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for MIST
- SEC Form 4 filed by Oliveto Joseph4 - Milestone Pharmaceuticals Inc. (0001408443) (Issuer)
- SEC Form 3 filed by new insider Sandoval David I.3 - Milestone Pharmaceuticals Inc. (0001408443) (Issuer)
- Amendment: SEC Form 4 filed by Chief Medical Officer Bharucha David4/A - Milestone Pharmaceuticals Inc. (0001408443) (Issuer)
- Amendment: SEC Form 4 filed by President and CEO Oliveto Joseph4/A - Milestone Pharmaceuticals Inc. (0001408443) (Issuer)
- Amendment: SEC Form 4 filed by Chief Commercial Officer Muller Lorenz4/A - Milestone Pharmaceuticals Inc. (0001408443) (Issuer)
- Amendment: SEC Form 4 filed by Chief Operating Officer Nelson Jeffrey Edward4/A - Milestone Pharmaceuticals Inc. (0001408443) (Issuer)
- Amendment: SEC Form 4 filed by CFO & EVP of Corp. Development Hasija Amit4/A - Milestone Pharmaceuticals Inc. (0001408443) (Issuer)
- SEC Form 4 filed by Chief Commercial Officer Muller Lorenz4 - Milestone Pharmaceuticals Inc. (0001408443) (Issuer)
- SEC Form 4 filed by CFO & EVP of Corp. Development Hasija Amit4 - Milestone Pharmaceuticals Inc. (0001408443) (Issuer)
- SEC Form 4 filed by Chief Operating Officer Nelson Jeffrey Edward4 - Milestone Pharmaceuticals Inc. (0001408443) (Issuer)
- SEC Form 4 filed by President and CEO Oliveto Joseph4 - Milestone Pharmaceuticals Inc. (0001408443) (Issuer)
- SEC Form 4 filed by Chief Medical Officer Bharucha David4 - Milestone Pharmaceuticals Inc. (0001408443) (Issuer)
- CFO & EVP of Corp. Development Hasija Amit was granted 100,000 shares, sold $158,209 worth of shares (70,252 units at $2.25) and converted options into 20,100 shares, increasing direct ownership by 100% to 99,848 units (SEC Form 4)4 - Milestone Pharmaceuticals Inc. (0001408443) (Issuer)
- Chief Medical Officer Bharucha David was granted 100,000 shares, sold $158,209 worth of shares (70,252 units at $2.25) and converted options into 20,100 shares, increasing direct ownership by 79% to 113,181 units (SEC Form 4)4 - Milestone Pharmaceuticals Inc. (0001408443) (Issuer)
- Chief Operating Officer Nelson Jeffrey Edward sold $158,209 worth of shares (70,252 units at $2.25), converted options into 20,100 shares and was granted 100,000 shares (SEC Form 4)4 - Milestone Pharmaceuticals Inc. (0001408443) (Issuer)
- Chief Commercial Officer Muller Lorenz converted options into 20,100 shares, was granted 100,000 shares and sold $145,851 worth of shares (64,746 units at $2.25), increasing direct ownership by 37% to 205,406 units (SEC Form 4)4 - Milestone Pharmaceuticals Inc. (0001408443) (Issuer)
- President and CEO Oliveto Joseph was granted 280,000 shares, sold $375,315 worth of shares (167,577 units at $2.24) and converted options into 66,600 shares, increasing direct ownership by 59% to 482,744 units (SEC Form 4)4 - Milestone Pharmaceuticals Inc. (0001408443) (Issuer)
- President and CEO Oliveto Joseph sold $97,875 worth of shares (43,500 units at $2.25), decreasing direct ownership by 13% to 303,721 units (SEC Form 4)4 - Milestone Pharmaceuticals Inc. (0001408443) (Issuer)
- Chief Commercial Officer Muller Lorenz gifted 25,000 shares, decreasing direct ownership by 14% to 150,052 units (SEC Form 4)4 - Milestone Pharmaceuticals Inc. (0001408443) (Issuer)
- CFO & EVP of Corp. Development Hasija Amit was granted 50,000 shares (SEC Form 4)4 - Milestone Pharmaceuticals Inc. (0001408443) (Issuer)
- Director Liebert Debra K. was granted 16,666 shares, increasing direct ownership by 13,123% to 16,793 units (SEC Form 4)4 - Milestone Pharmaceuticals Inc. (0001408443) (Issuer)
- Chief Medical Officer Bharucha David was granted 53,333 shares, increasing direct ownership by 533% to 63,333 units (SEC Form 4)4 - Milestone Pharmaceuticals Inc. (0001408443) (Issuer)
- Director Wills Robert James was granted 50,000 shares, increasing direct ownership by 333% to 65,000 units (SEC Form 4)4 - Milestone Pharmaceuticals Inc. (0001408443) (Issuer)
- President and CEO Oliveto Joseph was granted 66,666 shares, increasing direct ownership by 24% to 347,221 units (SEC Form 4)4 - Milestone Pharmaceuticals Inc. (0001408443) (Issuer)
- Director Papa Joseph C was granted 100,000 shares (SEC Form 4)4 - Milestone Pharmaceuticals Inc. (0001408443) (Issuer)
- Chief Commercial Officer Muller Lorenz was granted 66,666 shares, increasing direct ownership by 62% to 175,052 units (SEC Form 4)4 - Milestone Pharmaceuticals Inc. (0001408443) (Issuer)
- SEC Form 4 filed by Director Saik Andrew4 - Milestone Pharmaceuticals Inc. (0001408443) (Issuer)
- SEC Form 4 filed by Director Giles Lisa M.4 - Milestone Pharmaceuticals Inc. (0001408443) (Issuer)
- SEC Form 4 filed by Director Tomsicek Michael John4 - Milestone Pharmaceuticals Inc. (0001408443) (Issuer)
- SEC Form 4 filed by Director Papa Joseph C4 - Milestone Pharmaceuticals Inc. (0001408443) (Issuer)
- SEC Form 4 filed by Director Wills Robert James4 - Milestone Pharmaceuticals Inc. (0001408443) (Issuer)
- SEC Form 4 filed by Director Duty Stuart4 - Milestone Pharmaceuticals Inc. (0001408443) (Issuer)
- SEC Form 4 filed by Director Fischer Seth H. Z.4 - Milestone Pharmaceuticals Inc. (0001408443) (Issuer)
- SEC Form 4 filed by Chief Operating Officer Nelson Jeffrey Edward4 - Milestone Pharmaceuticals Inc. (0001408443) (Issuer)
- SEC Form 4 filed by Chief Commercial Officer Muller Lorenz4 - Milestone Pharmaceuticals Inc. (0001408443) (Issuer)
- SEC Form 4 filed by CFO & EVP of Corp. Development Hasija Amit4 - Milestone Pharmaceuticals Inc. (0001408443) (Issuer)
- SEC Form 4 filed by Chief Medical Officer Bharucha David4 - Milestone Pharmaceuticals Inc. (0001408443) (Issuer)
- SEC Form 4 filed by President and CEO Oliveto Joseph4 - Milestone Pharmaceuticals Inc. (0001408443) (Issuer)
- SEC Form 4 filed by Director Papa Joseph C4 - Milestone Pharmaceuticals Inc. (0001408443) (Issuer)
- SEC Form 3 filed by new insider Papa Joseph C3 - Milestone Pharmaceuticals Inc. (0001408443) (Issuer)
- SEC Form 4 filed by Director Giles Lisa M.4 - Milestone Pharmaceuticals Inc. (0001408443) (Issuer)
- SEC Form 4 filed by Director Tomsicek Michael John4 - Milestone Pharmaceuticals Inc. (0001408443) (Issuer)
- SEC Form 4 filed by Director Saik Andrew4 - Milestone Pharmaceuticals Inc. (0001408443) (Issuer)
- SEC Form 4 filed by Director Wills Robert James4 - Milestone Pharmaceuticals Inc. (0001408443) (Issuer)
- SEC Form 4 filed by Director Fischer Seth H. Z.4 - Milestone Pharmaceuticals Inc. (0001408443) (Issuer)
- SEC Form 4 filed by Director Duty Stuart4 - Milestone Pharmaceuticals Inc. (0001408443) (Issuer)
- SEC Form 4 filed by Director Saik Andrew4 - Milestone Pharmaceuticals Inc. (0001408443) (Issuer)
- SEC Form 3 filed by new insider Saik Andrew3 - Milestone Pharmaceuticals Inc. (0001408443) (Issuer)
- SEC Form 4 filed by Director Duty Stuart4 - Milestone Pharmaceuticals Inc. (0001408443) (Issuer)
- SEC Form 3 filed by new insider Duty Stuart3 - Milestone Pharmaceuticals Inc. (0001408443) (Issuer)
- SEC Form 4 filed by Wills Robert James4 - Milestone Pharmaceuticals Inc. (0001408443) (Issuer)
- SEC Form 4 filed by Tomsicek Michael John4 - Milestone Pharmaceuticals Inc. (0001408443) (Issuer)
- SEC Form 4 filed by Pasternak Richard C4 - Milestone Pharmaceuticals Inc. (0001408443) (Issuer)
- SEC Form 4 filed by Liebert Debra K.4 - Milestone Pharmaceuticals Inc. (0001408443) (Issuer)
- SEC Form 4 filed by Giles Lisa M.4 - Milestone Pharmaceuticals Inc. (0001408443) (Issuer)
- SEC Form 4 filed by Fischer Seth H. Z.4 - Milestone Pharmaceuticals Inc. (0001408443) (Issuer)
- SEC Form 4 filed by Rtw Investments, Lp4 - Milestone Pharmaceuticals Inc. (0001408443) (Issuer)
- SEC Form 4 filed by Fischer Seth H. Z.4 - Milestone Pharmaceuticals Inc. (0001408443) (Issuer)
- SEC Form 3 filed by new insider Fischer Seth H. Z.3 - Milestone Pharmaceuticals Inc. (0001408443) (Issuer)
- SEC Form 4 filed by Muller Lorenz4 - Milestone Pharmaceuticals Inc. (0001408443) (Issuer)